These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 35399726)
1. Mir-454-3p induced WTX deficiency promotes hepatocellular carcinoma progressions through regulating TGF-β signaling pathway. Liu H; Zheng J; Yang S; Zong Q; Wang Z; Liao X J Cancer; 2022; 13(6):1820-1829. PubMed ID: 35399726 [No Abstract] [Full Text] [Related]
2. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635 [TBL] [Abstract][Full Text] [Related]
3. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression. Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. Zhang QY; Men CJ; Ding XW J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma. Zhang T; Liu W; Meng W; Zhao H; Yang Q; Gu SJ; Xiao CC; Jia CC; Fu BS Onco Targets Ther; 2018; 11():1929-1939. PubMed ID: 29670368 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3. Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005 [TBL] [Abstract][Full Text] [Related]
8. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
9. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells. Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631 [TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma. Tang SJ; Yang JB Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966 [TBL] [Abstract][Full Text] [Related]
11. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3. Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760 [TBL] [Abstract][Full Text] [Related]
12. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
13. miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2. Zuo XL; Chen ZQ; Wang JF; Wang JG; Liang LH; Cai J Am J Cancer Res; 2018; 8(4):662-674. PubMed ID: 29736311 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p. Li Z; Hu Y; Zeng Q; Wang H; Yan J; Li H; Yu Z Cancer Cell Int; 2019; 19():211. PubMed ID: 31413665 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9. Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723 [TBL] [Abstract][Full Text] [Related]
16. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion. Ye Y; Song Y; Zhuang J; Wang G; Ni J; Zhang S; Xia W Onco Targets Ther; 2018; 11():8175-8184. PubMed ID: 30573969 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372 [TBL] [Abstract][Full Text] [Related]
19. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Zhang N; Chen X Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159 [TBL] [Abstract][Full Text] [Related]
20. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET. Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]